Pharmacology and Dental Implications of Novel Oral Anticoagulants
(Sprache: Englisch)
Novel oral anticoagulants (NOACs), direct thrombin inhibitor (dabigatran) and factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) are available in market as an alternative to warfarin. They are widely being prescribed by medical practitioners as these...
Leider schon ausverkauft
versandkostenfrei
Buch
28.90 €
Produktdetails
Produktinformationen zu „Pharmacology and Dental Implications of Novel Oral Anticoagulants “
Klappentext zu „Pharmacology and Dental Implications of Novel Oral Anticoagulants “
Novel oral anticoagulants (NOACs), direct thrombin inhibitor (dabigatran) and factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) are available in market as an alternative to warfarin. They are widely being prescribed by medical practitioners as these drugs overcome some of the major drawbacks with the existing medications. Absence of any specific management guidelines and lack of antidote are major concern for dental treatment of patients on NOACs. This review details the pharmacological profile of vitamin K anticoagulants and emerging NOACs. In order to assist dental professionals in decision making, case studies showing management of patients on NOACs undergoing dental treatment are also summarized. Since available data are not sufficient to establish an evidence-based dental management, the dentist must use caution and attention when treating patients taking dabigatran, rivaroxaban, apixaban and edoxaban.
Bibliographische Angaben
- Autoren: Uday Reebye , Kevin Fortier , William Kirk
- 2016, 52 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3330012161
- ISBN-13: 9783330012165
Sprache:
Englisch
Kommentar zu "Pharmacology and Dental Implications of Novel Oral Anticoagulants"
0 Gebrauchte Artikel zu „Pharmacology and Dental Implications of Novel Oral Anticoagulants“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Pharmacology and Dental Implications of Novel Oral Anticoagulants".
Kommentar verfassen